Introduction
Studies of the function and endocrinology of vitamin D, over the last 80 years have elucidated the role of this prohormone in regulating calcium and phosphate concentrations in blood. During this period, great increases in our understanding of the significance of vitamin D have taken place. First the identification of the antirachitic factor and its importance in controlling blood calcium and phosphate levels was a major insight in basic physiology and had important therapeutic application. Secondly, studies on the metabolism of vitamin D led to the identification of the hormone, 1,25-dihydroxyvitamin D, or calcitriol. This discovery resulted in the rationale for clinical use of calcitriol in renal disease and increased our understanding of the basic mechanisms and action of this steroid hormone. The expression of vitamin D action is now known to involve the functioning of intracellular receptors, the regulation of gene transcription and the translation of mRNA. Initially, investigators extensively characterized a specific receptor for 1 ,25dihydroxyvitaminD3in intestine and bone. Recently, calcitriol receptors have been characterized in tissues not originally recognized ascalcitriol respon~ive.l-~ Subsequent in vivo and in vitro studies have to some extent corroborated receptor studies and demonstrated previously unappreciated functions for calcitriol. Current data now suggest that 1,25-dihydroxyvitamin D, affects the functioning of organ systems that are not directly responsible for regulation of blood calcium and phosphate. We refer to excellent reviews on the vitamin D system as sources of reference for much of the discussion in this text.4" It is the intention of this report to review the recent studies and summarize the information that pertains to our expanded view of calcitriol for health. Our intention is also to suggest future possible pharmacologically important uses for the vitamin D hormone.
REVIEW ARTICLES Regulation of Vitamin D3 Metabolism
The observation that a time lag exists between vitamin D, administration in viuo and changes in bone and intestinal metabolism, together with the finding that vitamin D, lacks activity in vitro, suggested that vitamin D, required bioactivation to produce its effects. Subsequent studies established that a metabolite of vitamin D,, 1,25-dihydroxyvitamin D, (calcitriol), is the functionally active form of the vitamin, and that its metabolism is tightly controlled.
The bioactivation of vitamin D, can be influenced by a number of factors, including serum calcium and phosphate levels, calcitriol itself, parathyroid hormone, estradiol and prolactin. Circulating levels of calcitriol are increased in response to reductions in serum levels of calcium and phosphate. This response is apparently mediated in part by parathyroid hormone, since it has been shown that parathyroid hormone exerts a direct stimulatory effect on l-ahydroxylase activity.' In addition, parathyroidectomy has been shown to blunt the increase in circulating calcitriol levels observed during lactation in rat^.^-^ Estradiol and prolactin also stimulate the bioactivation of calcitriol, and the dopamine agonist bromocryptine -which decreases prolactin secretion -has been shown to lower plasma levels of calcitriol in rat^.^-^ Organs involved in regulating 1,25-dihydroxyvitamin D, metabolism in vivo are illustrated in Fig. 1 To date, no compound has been identified which exerts a classic antagonist effect (high-affinity binding, no intrinsic activity) on the intracellular vitamin D receptor. However, a number of agents have been shown to impair calcitriol synthesis and may, therefore, be considered to 'antagonize' the response to vitamin D,. Such agents include inhibitors of 25-hydroxylase such as 24-nor-25-hydroxy vitamin D,, which also lacks intrinsic vitamin D receptor 'agonist' a~tivity.*-~ Several metabolites of vitamin D, have been shown to inhibit 1-a-hydroxylase activity; however, these metabolites also possessed intrinsic receptor 'agonist' a~t i v i t y .~-~
I ntest i ne
Our greatest understanding of the mechanism of action of calcitriol on subcellular processes comes from studies of its effects on the intestine. Vitamin D, acting via its metabolite, calcitriol, stimulates Ca2+ transport from the lumen of the intestine through the cell and into the blood. Along with the intestinal transport of Ca2+, calcitriol stimulates the transport of PO,2-from intestinal lumen to b l o~d .~-~ It is now recognized that calcitriol induces the synthesis of a cytosolic CaBP.l0 This action most likely does not account for all the processes activated by calcitriol and required for calcium transport across the intestinal epithelia. Therefore, many studies have concerned themselves with identifying other proteins or factors that are synthesized in intestine and under the control of calcitriol. For example, a membrane-bound calciumbinding protein complex possessing phosphatase activity has been reported to be under the direct control of vitamin D." A different mechanism of actionalteration of membrane phospholipid composition -for calcitriol has been supported by Rasmussen and coworkers.12 These data suggest that the activity of calcitriol might not be explained entirely by the activation of nuclear transcription of specific genes. Clearly, much work remains to be done before a clear understanding of how calcitriol affects intestinal cell processes is reached.
Osteoporosis
Vitamin D-dependent rickets was cured with the therapeutic application of the anti-ricket factor vitamin D. Recently, it
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was also shown that calcitriol is of great therapeutic use in treatment of such diseasesasrenal osteodystrophy, vitamin D-resistant rickets due to an inborn error of vitamin D metabolism, and certain hypoparathyroid disorder^.^" Osteoporosis is an age-related disorder that affects over 15 million persons in the United States. The bone wasting associated with this disease suggests the possible therapeutic usefulness of calcitrio1 for the treatment of osteoporosis. Initial clinical studies focused on the action of the prohormone, vitamin D, on postmenopausal osteopor~sis.~~ These studies did not demonstrate a therapeutic use of vitamin D for treatment of osteoporosis. It has been argued that use of vitamin D for the treatment of postmenopausal osteoporosis has not been effective due to decreased metabolism of vitamin D to the active metabolite calcitriol in the aged.14 Analysis of serum calcitriol supports this contention, showing that postmenopausal women have a significant decrease in serum calcitriol levels. Studies using 0.25 pg calcitriol showed that calcitriol was ineffective in treating this disease.15 Others, however, using higher concentrations of calcitriol, have demonstrated significant improvement of bone parameters in osteoporetic patients.I6 Further clinical testing of calcitriol for the treatment of postmenopausal osteoporosis is on-going and essential for establishing the therapeutic usefulness of calcitriol.
Kidney
A major action of calcitriol is to regulate renal 25-hydroxyvitamin D,-l-ahydroxylase (la(0H)ase). It has been shown that calcitriol brings about a suppression of la(0H)ase concomitant with an increase in 25-hydroxyvitamin D3-24-hydroxylase (24(OH)ase). These observations have been supported by in vivo and in vitro This action of calcitriol is analogous to the action of other steroid hormones to effect a feedback inhibition of their synthesis. The feedback inhibition of la(0H)ase is dependent on blood calcium concentrations since it has been observed that calcitriol will, in fact, stimulate its own synthesis in hypocalcemic animals.
Possible actions of calcitriol on renal calcium and phosphate handling are not at present fully characterized. Studies have shown that vitamin D increases renal retention of calcium. Also, it has been shown that vitamin D increases renal absorption of phosphate. However, these in viuo studies could not eliminate the possible secondary action of other renal active agents to elicit these effects. In spite of this, calcitriol receptors have been demonstrated in distal renal tubule cells, cultured kidney cells and kidney h~m o g e n a t e s .~-~ Further evidence that calcitriol has a direct effect on kidney functions comes in the data showing that a specific vitamin D-dependent calcium-binding protein is present in kidney tubule cells.
Vitamin D and Skeletal Muscle
Several authors have suggested a potential role for vitamin D in the regulation of skeletal muscle contractile function. Such involvement is based upon the observation that vitamin D deficiency is associated with skeletal muscle myopathy and muscle fibre atrophy, conditions which are reversible upon administration of vitamin D or its metab01ites.l~ In addition, Curry et al. have shown that the rate of calcium uptake by skeletal muscle sarcoplasmic reticulum isolated from vitamin D-deficient rabbits is significantly reduced compared with that of sarcoplasmic reticulum isolated from normal rabbits.'* This reduction is apparently not related to any change in the ATPase activity of the sarcoplasmic reticulum. We reported that receptors for calcitriol exist in skeletal muscle myoblasts and at significantly lower concentrations in excised muscle tissue.lg Others have demonstrated that calcitriol stimulated calcium transport in cultured muscle myoblasts.20 A possible dihydroxyvitamin 1,25D, specific effect on muscle myoblasts is currently being studied in our laboratory.
In a recent study, Wassner and co-workers reported that weight gain and skeletal muscle mass were reduced in vitamin D-deficient rats, and that myofibrillar protein degradation was increased.21 According to the authors, these changes were associated with the onset of hypocalcemia and could be reversed by the addition of vitamin D to the diet or by feeding the vitamin D-deficient rats diets that contained sufficient quantities of calcium to restore circulating calcium to normal levels. Thus, although vitamin D repletion leads to improved muscle protein anabolism and an increase in skeletal muscle mass and weight gain, these effects have yet to be proved to be a result of the direct action of vitamin D or a vitamin D-derived metabolite on skeletal muscle. The observations that calcitriol receptors exist in leukemia cells and that calcitriol stimulates differentiation of these cells into mature monocytes suggests that the hormone may be involved in the regulation of monocyte differentiation. Recently, this work has been extended to show that calcitriol stimulates the aggregation of precursor cells into poly-nuclear osteoclastic-like cells. This process was suggested as a possible mechanism for calcitriolinduced osteoclastic bone reabsorption. Receptors for calcitriol have also been characterized in activated T cells.30 Therefore, a function for calcitriol in the immune response may exist.
Skin, Brain and Sex Tissue
Calcitriol receptors have been demonstrated in mammary and skin A possible role of calcitriol in calcium handling by skin, sweat glands and mammary glands is suggested. However, little data on hormone action have been presented. An increase in 7-dehydrocholesterol levels in skin due to calcitriol has been identified. This suggests that calcitriol may have a feedback-inhibitory action on the synthesis of vitamin D, in skin (see ref. 
Exocrine Function of Calcitriol
The presence of calcitriol receptors in parathyroid, pancreas, testes, ovaries and pituitary has raised the possibility of a direct action of this hormone in the regulation of hormone synthesis and secretion. We will review the data presented to support a functional role of calcitriol in exocrine cell processes. In 1980, Norman and co-workers demonstrated that vitamin D deficiency inhibited insulin secretion from the perfused pancreas, whereas vitamin D repletion improved insulin ~ecretion.,~ An involvement of vitamin D with insulin secretion is also implicated by the observation that although pancreatic levels of CaBP are low compared with levels in the intestine or the kidney, pancreatic CaBP is present exclusively in the B-cek5 Together these observations imply a physiological role for vitamin D in modulating calcium metabolism in the pancreas, and indicate that vitamin D may exert an influence on insulin secretion as well. However, vitamin D deficiency also leads to decreased food intake and hypocalcemia. The direct action of calcitriol on insulin secretion therefore remains to be firmly established.
Pancreas

Parathyroid
There is in vivo and in vitro evidence to support a direct action of calcitriol in regulating secretion of parathyroid hormone (PTH) from the parathyroid gland. Evidence has been presented showing that a calcitriol receptor exists in excised parathyroid tissue from avian and mammalian species.34 Furthermore, immunochemical vitamin D-dependent CaBP have been localized to the p a r a t h y r~i d .~~
Functional studies have suggested that calcitriol in normal calcemia can suppress the secretion of PTH. However, in vitro studies designed to demonstrate a direct action of calcitriol on parathyroid tissue have yielded ambiguous data. It has been shown that calcitriol inhibited, stimulated or had no effect on release of PTH from parathyroid cells dosed in vitro (for review see ref.
3). These discrepancies in results might be explained by the nutritional status of tested animals or in terms of the in vitro incubation conditions for PTH release. Recent studies, however, do support an in uiuo role for calcitriol in regulation of PTH secretion^.^'
Pituitary
Pituitary cells have been shown to possess specific calcitriol receptors and the vitamin D-dependent calciumbinding protein.l* 34 It has recently been shown that calcitriol has a specific and selective action to increase prolactin synthesis and secretion from pituitary cells.38 This has been shown measuring the peptide and specific mRNAs for prolactin. The effect of 1,25-dihydroxyvitamin D, on prolactin mRNA synthesis was diminished in lowcalcium-containing media. These findings demonstrate that calcitriol stimulates prolactin gene expression and that calcium is involved in this expression. In addition, autoradiography and immunohistochemistry techniques have provided evidence that calcitriol specifically localizes in those cells that secrete thyroid-stimulating hormone.39 These data indirectly suggest that calci-
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triol may modulate thyroid hormone secretion.
The presence of receptors for calcitriol in exocrine tissues suggests a functional role for calcitriol in endocrine-controlled processes. However, with the exception of the action of calcitriol on PTH secretion, aclear picture of the regulation of hormone secretion by calcitriol remains to be established, and further studies are required to translate in vitro observations of calcitriol secretory control to in viva relevance.
Conclusions
During the last two decades the important role of calcitriol in regulating bone mineralization and intestinal calcium transport has been well documented. Moreover, the ability of calcitriol to treat renal osteodystrophy has been firmly established. In addition, clinical studies are currently under way that are aimed at demonstrating the ability of calcitriol to prevent the onset or retard the progression of osteoporosis.
Several recent studies have shown that in addition to its effect on bone, intestine and kidney metabolism, calcitriol may play an important role in regulating key metabolic processes in a number of other organs and cells, including pancreas, skin, cancer cells, cardiac and skeletal muscle, brain, parathyroid gland, testes and ovaries. These processes include insulin secretion, muscle contractility, cell differentiation and melanin synthesis. Such discoveries have prompted interest in the potential utility of vitamin D receptor agonists and antagonists, and agents which may influence 1,25-dihydroxyvitamin D, action as potential therapeutic agents for the treatment of diabetes, cancer, muscle myopathy, and other pathological conditions. Although there exists a paucity of such compounds, the tissue-selective effects of an analog of vitamin D indicate that it may be possible to design agents which limit the potent hypercalcemic effect of 1,25-dihydroxyvitamin D,. If made available, tissue-specific calcitriol agonists and antagonists may provide useful therapeutic agents for novel treatment of endocrine diseases. 
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Human Choriogonadotropin David Puett Summary
Human choriogonadotropin, a hormone derived from the syncytiotrophoblast cells of the placenta, is a member of the glycoprotein hormone family which also contains the pituitary hormones lutropin, follitropin and thyrotropin. These four hormones are comprised of two dissimilar subunits, one (a) being common to all four and the other (J) conferring hormonal specificity. Information is rapidly accumulating on rhe nature and regulation of the genes for these subunits, as well as the structural aspects, mechanism-of-action and physiological roles of these complex hormones. This mini review considers some of the recent advances in our understanding of human choriogonadotropin.
The Glycoprotein Hormones
There are four characterized members of the human (h) glycoprotein hormone family : choriogonadotropin (CG, generally designated as hCG), lutropin (LH, luteinizing hormone), follitropin (FSH, follicle-stimulating hormone) and thyrotropin (TSH, thyroid-stimulating hormone). hCG is a product of the syncytiotrophoblast cells of the placenta, and the other hormones are synthesized in and secreted by specific cell types of the adenohypophysis (i.e. the anterior lobe of the pituitary). There has also been a suggestion of an hCG-like material in human pituitary, and hCG and subunits are secreted by certain tumors. Each hormone contains a common a subunit and hormone-specific B subunit; only the a/3 complex (Fig. 1) exhibits significant biological activity. 
